Weak India performance; cut estimates by 11-12%
Lower operating leverage further affects profitability
* CIPLA delivered a weaker-than-expected performance in 4QF..
Decent results; Outlook promising
Cipla is a leading global pharmaceutical company with 1,500 plus products across various therapeutic categories. It has presence in o..
Construction firm J Kumar Infraprojects bags Rs 1,307.8 cr order from MMRDA
Civil engineering and construction company J Kumar Infraprojects Ltd on Monday ..
Misses estimates; focus remains intact…
Q4 revenues grew 5.3% YoY to | 4606 crore. Domestic sales grew 4.5% YoY to | 1807 crore. US grew 17.1% YoY to | 1002 cro..
Below are Quote on Cipla launched Casirivimab and Imdevimab, another drug to fight against Covid 19 in India by Mr. Yash Gupta Equity ..
Roche India on Monday announced the rollout of its first batch of the antibody cocktail (Casirivimab and Imdevimab) against Coronavirus in India. The cocktail drug will b..
Weak Q4; on track to sustain higher margins
Cipla reported weak Q4FY21 performance due to shelf stock adjustment of Albuterol in US and muted India growth. However, w..
Below are Quote on Cipla Ltd up by 2% on announcement of ‘ViraGen’ for COVID-19 by Mr. Yash Gupta Equity Research Associate, A..
Cipla is currently trading at Rs. 912.85, up by 8.80 points or 0.97% from its previous closing of Rs. 884.15 on the BSE.
The scrip opened at Rs. 906.00 and has touched..
Religare Super Idea
To Read Complete Report & Disclaimer Click Here
Please refer disclaimer http://ex.religareonline.com/disclaimer..
Below are Quote on Cipla - 4QFY21 by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd
Cipla reported a number in ..
Rupee strengthens against US dollar on Tuesday
Rupee falls 10 paise to 73.94 against US dollar in early trade
NCLT approves sale of IL&FS education arm to LEHL
Rate decision, US stimulus likely constraints to rupee's further appreciation
Rupee slips on RBI's dovish stance, 'loose' policy
Nifty at 15800 but midcap index at crucial juncture now By by Sameet Chavan, Angel Broking
GST cuts for several Covid-relief items; no change in vax tax
India cuts taxes on some COVID-19 medicines and equipment
Oil PSUs to support various Art & Handicraft projects
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface